Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mark Kowalski, Ian Mortimer, Jeffrey Jonas

Premium

Tekmira Pharmaceuticals has appointed Mark Kowalski as its chief medical officer.

Before joining Tekmira, he was chief medical officer of YM BioSciences. He joined Gilead Sciences following its acquisition of YM.


Tekmira also disclosed that its CFO Ian Mortimer will leave the company Oct. 15. He has been with Tekmira for five years.

The search for a new CFO is underway.


Sage Therapeutics has named Jeffrey Jonas as its new CEO.

Jonas previously served as executive vice president of Isis Pharmaceuticals.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.